Pathovax, LLC

BALTIMORE, MD 21205

SBIR Award Summary

Total Number of Awards 1
Total Value of Awards $300K
First Award Date 09/21/17
Most Recent Award Date 09/21/17

Key Personnel

Last Name Name Awards Contact
WANG JOSHUA WEIYUAN WANG 1

1 Award Won

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-16-303
Budget: 09/21/17 - 08/31/18

The broader impact/commercial potential of PathoVax?s STTR phase I proposal is to improve outcomes of cancer immuno-therapy, utilizing a vaccine formulation combining an immunogenic chimeric virus-like particle (cVLP) vaccine with FDA-approved immune check-point inhibitors. PathoVax proposes to develop this technology for treatment of human papi...